4.8 Article

Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1612906114

Keywords

organ-on-a-chip; microbioreactor; electrochemical biosensor; physical sensor; drug screening

Funding

  1. Defense Threat Reduction Agency under Space and Naval Warfare Systems Center Pacific [N66001-13-C-2027]
  2. Office of Naval Research Young National Investigator Award
  3. National Institutes of Health [EB012597, AR057837, DE021468, HL099073, R56AI105024, AR068258, AR066193, EB022403, EB021148]
  4. Presidential Early Career Award for Scientists and Engineers
  5. National Cancer Institute of the National Institutes of Health Pathway to Independence Award [K99/R00, K99CA201603]

Ask authors/readers for more resources

Organ-on-a-chip systems are miniaturized microfluidic 3D human tissue and organ models designed to recapitulate the important biological and physiological parameters of their in vivo counterparts. They have recently emerged as a viable platform for personalized medicine and drug screening. These in vitro models, featuring biomimetic compositions, architectures, and functions, are expected to replace the conventional planar, static cell cultures and bridge the gap between the currently used preclinical animal models and the human body. Multiple organoid models may be further connected together through the microfluidics in a similar manner in which they are arranged in vivo, providing the capability to analyze multiorgan interactions. Although a wide variety of human organ-on-a-chip models have been created, there are limited efforts on the integration of multisensor systems. However, in situ continual measuring is critical in precise assessment of the microenvironment parameters and the dynamic responses of the organs to pharmaceutical compounds over extended periods of time. In addition, automated and noninvasive capability is strongly desired for long-term monitoring. Here, we report a fully integrated modular physical, biochemical, and optical sensing platform through a fluidics-routing breadboard, which operates organ-on-a-chip units in a continual, dynamic, and automated manner. We believe that this platform technology has paved a potential avenue to promote the performance of current organ-on-a-chip models in drug screening by integrating a multitude of real-time sensors to achieve automated in situ monitoring of biophysical and biochemical parameters.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available